WHO ICTRP trial
To determine the efficacy of GV22202 in subjects with mild knee osteoarthritis
CTRI/2023/04/051793 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2023/04/051793 |
|---|---|
| Public title | To determine the efficacy of GV22202 in subjects with mild knee osteoarthritis |
| Scientific title | A Randomized, Double-Blind, Placebo and an Active Comparator Controlled Parallel-Group Study to Evaluate the Efficacy of GV22202 in Subjects With Mild Knee Osteoarthritis. |
| Primary sponsor | GeneVec |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: M179- Osteoarthritis of knee, unspecified |
| Registration date | Apr 19, 2023 |
| Target size | 150 |
| Secondary IDs | GV/OA/GV22202/22 Protocol Version 01 30-Jun-2022 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: